What could explain the high prevalence of progressive fibrosing interstitial lung disease in a patient registry?

Eur Respir J. 2023 Apr 1;61(4):2300019. doi: 10.1183/13993003.00019-2023. Print 2023 Apr.

Authors

Onofre Moran-Mendoza^{1

2}, Ahmad Al-Jarallah^{3

2}, Salem Alqahtani^{3

2}, Carla Paredes²

Affiliations

¹ Division of Respirology and Sleep Medicine, Queen's University, Kingston, ON, Canada morano@queensu.ca.
² Kingston Health Sciences Center, Kingston, ON, Canada.
³ Division of Respirology and Sleep Medicine, Queen's University, Kingston, ON, Canada.

PMID: 37003616
DOI: 10.1183/13993003.00019-2023

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Lung Diseases, Interstitial* / epidemiology
Prevalence
Pulmonary Fibrosis* / complications
Pulmonary Fibrosis* / epidemiology